Active09331313Private limited companyUxbridge

OXULAR LIMITED

Owned by Regeneron Pharmaceuticals, Inc. (75–100%)

Companies HouseCompanies House

From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms

01

Summary

Generated from filed data · no estimates

OXULAR LIMITED is an active private limited company (company number 09331313) incorporated on 27 November 2014, registered in Uxbridge. Its registered activity is research and experimental development on biotechnology (SIC 72110). Accounts are on file at Companies House (total exemption full) but not yet parsed into this record.

There are 151 companies in research and experimental development on biotechnology in Greater London with filed accounts; the median reports net assets of £200 and is 8 years old.

02

Key dates

Incorporated
27 November 201411 yrs ago
First accounts due
27 August 20163708 days overdue
Confirmation statement due
11 December 2026in 50 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

03

Activity

SIC 72110
Research and experimental development on biotechnology
Accounts type
Total Exemption Full
04

Financials

No accounts on record

Accounts exist on the register but their figures are not in this dataset yet.

05

Filing and accounts signals

Facts from the register · no rating
  • Incorporated five or more years agoIncorporated 2014-11-27 (12 years)
  • Accounts overdueDue 2016-08-27

Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.

06

Ownership and control

1 active · 1 other
  • Regeneron Pharmaceuticals, Inc.
    corporate entity, United States · since 20 December 2024
    • owns 75–100% of shares
    • holds 75–100% of voting rights
    • can appoint or remove directors
  • persons with significant control statement · since 27 November 2016 · ceased 20 December 2024

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.

07

Timeline

Newest first
  1. Confirmation statement duein 50 days
  2. First accounts due3708 days overdue
  3. Incorporated
08

Similar companies in Greater London

Same activity (research and experimental development on biotechnology), closest in incorporation date
09

Reminders for OXULAR LIMITED

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.

Source: Companies House register, snapshot 2026-08-31. Open Government Licence v3.0. View on Companies House. Methodology · About · Markdown.